Literature DB >> 28027395

Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?

Lauren S Whyte1,2, Adeline A Lau1, Kim M Hemsley1, John J Hopwood1, Timothy J Sargeant1.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia, and its prevalence will increase significantly in the coming decades. Although important progress has been made, fundamental pathogenic mechanisms as well as most hereditary contributions to the sporadic form of the disease remain unknown. In this review, we examine the now substantial links between AD pathogenesis and lysosomal biology. The lysosome hydrolyses and processes cargo delivered by multiple pathways, including endocytosis and autophagy. The endo-lysosomal and autophagic networks are central to clearance of cellular macromolecules, which is important given there is a deficit in clearance of amyloid-β in AD. Numerous studies show prominent lysosomal dysfunction in AD, including perturbed trafficking of lysosomal enzymes and accumulation of the same substrates that accumulate in lysosomal storage disorders. Examination of the brain in lysosomal storage disorders shows the accumulation of amyloid precursor protein metabolites, which further links lysosomal dysfunction with AD. This and other evidence leads us to hypothesise that genetic variation in lysosomal genes modifies the disease course of sporadic AD.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; dementia; endosome; lysosomal storage disorder; lysosome; neurodegenerative disease

Mesh:

Year:  2017        PMID: 28027395     DOI: 10.1111/jnc.13935

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  49 in total

Review 1.  PPARα Between Aspirin and Plaque Clearance.

Authors:  Sujyoti Chandra; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions.

Authors:  Julia Obergasteiger; Giulia Frapporti; Giulia Lamonaca; Sara Pizzi; Anne Picard; Alexandros A Lavdas; Francesca Pischedda; Giovanni Piccoli; Sabine Hilfiker; Evy Lobbestael; Veerle Baekelandt; Andrew A Hicks; Corrado Corti; Peter P Pramstaller; Mattia Volta
Journal:  Cell Death Discov       Date:  2020-06-08

3.  Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.

Authors:  Josh M Krivinko; Susan L Erickson; Ying Ding; Zhe Sun; Peter Penzes; Matthew L MacDonald; Nathan A Yates; Milos D Ikonomovic; Oscar L Lopez; Robert A Sweet; Julia Kofler
Journal:  Am J Psychiatry       Date:  2018-07-19       Impact factor: 18.112

Review 4.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

Review 5.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 Cells.

Authors:  Zhihao Xu; Wenbin Nan; Xiaoyue Zhang; Yuliang Sun; Jichao Yang; Kecheng Lu; Yalin Liu; Yaoxin Gao; Fen Yang; Wenchao Mao; Xuekun Xing; Jiang Du; Han Li; Yonghai Li; Huigen Feng; Zhiqing Yuan; Juntang Lin
Journal:  J Mol Neurosci       Date:  2018-05-29       Impact factor: 3.444

7.  Regulation of phagolysosomal activity by miR-204 critically influences structure and function of retinal pigment epithelium/retina.

Authors:  Congxiao Zhang; Kiyoharu J Miyagishima; Lijin Dong; Aaron Rising; Malika Nimmagadda; Genqing Liang; Ruchi Sharma; Roba Dejene; Yuan Wang; Mones Abu-Asab; Haohua Qian; Yichao Li; Megan Kopera; Arvydas Maminishkis; Jennifer Martinez; Sheldon Miller
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

Review 8.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

Review 9.  Tau-targeting therapies for Alzheimer disease.

Authors:  Erin E Congdon; Einar M Sigurdsson
Journal:  Nat Rev Neurol       Date:  2018-07       Impact factor: 42.937

10.  Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.

Authors:  Sujyoti Chandra; Malabendu Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2018-07-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.